Evidence map›Paper›PMID 35111323›Full record

ArticleMolecular and clinical oncology2022

New considerations for colorectal cancer screening based on the demographic profile of colorectal cancer in a Greek population.

Vasileios Panteris, Panagiotis Karantanos, Nikolaos Vasilakis, Stephanie Vgenopoulou, Georgia Lymperopoulou, Georgios Feretzakis, Ilias Dalainas, Elias Kouroumalis

Abstract read
In one paragraph

Article in Molecular and clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vasileios PanterisGastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Panagiotis KarantanosGastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Nikolaos VasilakisGastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Stephanie VgenopoulouHistopathology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Georgia LymperopoulouGastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Georgios FeretzakisDepartment of Quality Control, Research and Continuing Education, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Ilias DalainasGeneral Manager, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.
Elias KouroumalisUniversity of Crete Medical School, 71500 Heraklion, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer screening has long been recommended for middle age and older individuals. Recent evidence indicates increasing incidence and mortality among young adults. Therefore, the present study re-examined the current recommendations using an asymptomatic average-risk population screened by colonoscopy. A total of 716 participants of a wide age range were prospectively enrolled in an open-access endoscopic screening program based on self-referral. Comparisons between different age, gender and location groups, and receiver operating characteristic curves (ROC) curves for best age selection for detection of lesions were employed. Increased incidence of advanced lesions was observed in adults <50 years old. Although the polyp size was <1 cm in 85% of the cohort, a significant number of participants harbored advanced lesions. A disturbing incidence of lesions in women 30-49 years was located mainly in the left colon. One-third of the important pathology resides exclusively in the right colon. ROC curves demonstrated that with the current starting age of screening at 50 years, 92% of polyps and 95% of adenomas could be detected by colonoscopy, but a number of potential precancerous lesions will appear at an earlier age and therefore will be missed. The present study supported the notion that it is critical to reduce screening initiation below the currently accepted age of 50 years. Colonoscopy is a suitable method for addressing the increased prevalence of proximal lesions and the meticulous resection of smaller polyps.

Indexed as

colonoscopycolorectal cancerGreek cohortpublic healthscreening

Identifiers

PMID35111323
PMCPMC8771310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.